Kuramitsu Madoka, Sekizuka Tsuyoshi, Yamochi Tadanori, Firouzi Sanaz, Sato Tomoo, Umeki Kazumi, Sasaki Daisuke, Hasegawa Hiroo, Kubota Ryuji, Sobata Rieko, Matsumoto Chieko, Kaneko Noriaki, Momose Haruka, Araki Kumiko, Saito Masumichi, Nosaka Kisato, Utsunomiya Atae, Koh Ki-Ryang, Ogata Masao, Uchimaru Kaoru, Iwanaga Masako, Sagara Yasuko, Yamano Yoshihisa, Okayama Akihiko, Miura Kiyonori, Satake Masahiro, Saito Shigeru, Itabashi Kazuo, Yamaguchi Kazunari, Kuroda Makoto, Watanabe Toshiki, Okuma Kazu, Hamaguchi Isao
Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Pathogen Genomic Center, National Institute of Infectious Diseases, Tokyo, Japan.
J Clin Microbiol. 2017 Sep;55(9):2838-2849. doi: 10.1128/JCM.00659-17. Epub 2017 Jul 12.
Western blotting (WB) for human T cell leukemia virus type 1 (HTLV-1) is performed to confirm anti-HTLV-1 antibodies detected at the initial screening of blood donors and in pregnant women. However, the frequent occurrence of indeterminate results is a problem with this test. We therefore assessed the cause of indeterminate WB results by analyzing HTLV-1 provirus genomic sequences. A quantitative PCR assay measuring HTLV-1 provirus in WB-indeterminate samples revealed that the median proviral load was approximately 100-fold lower than that of WB-positive samples (0.01 versus 0.71 copy/100 cells). Phylogenic analysis of the complete HTLV-1 genomes of WB-indeterminate samples did not identify any specific phylogenetic groups. When we analyzed the nucleotide changes in 19 HTLV-1 isolates from WB-indeterminate samples, we identified 135 single nucleotide substitutions, composed of four types, G to A (29%), C to T (19%), T to C (19%), and A to G (16%). In the most frequent G-to-A substitution, 64% occurred at GG dinucleotides, indicating that APOBEC3G is responsible for mutagenesis in WB-indeterminate samples. Moreover, interestingly, five WB-indeterminate isolates had nonsense mutations in Pol and/or Tax, Env, p12, and p30. These findings suggest that WB-indeterminate carriers have low production of viral antigens because of a combination of a low proviral load and mutations in the provirus, which may interfere with host recognition of HTLV-1 antigens.
进行1型人类T细胞白血病病毒(HTLV-1)的蛋白质免疫印迹法(WB),以确认在献血者和孕妇初筛时检测到的抗HTLV-1抗体。然而,该检测中经常出现不确定结果是一个问题。因此,我们通过分析HTLV-1前病毒基因组序列来评估WB不确定结果的原因。一项测量WB不确定样本中HTLV-1前病毒的定量PCR检测显示,前病毒载量中位数比WB阳性样本低约100倍(0.01对0.71拷贝/100个细胞)。对WB不确定样本的完整HTLV-1基因组进行系统发育分析,未发现任何特定的系统发育组。当我们分析来自WB不确定样本的19株HTLV-1分离株的核苷酸变化时,我们鉴定出135个单核苷酸替换,由四种类型组成,G到A(29%)、C到T(19%)、T到C(19%)和A到G(16%)。在最常见的G到A替换中,64%发生在GG二核苷酸处,表明载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)负责WB不确定样本中的诱变。此外,有趣的是,五株WB不确定分离株在聚合酶(Pol)和/或反式激活因子(Tax)、包膜蛋白(Env)、p12和p30中存在无义突变。这些发现表明,WB不确定携带者由于前病毒载量低和前病毒突变的组合,导致病毒抗原产生量低,这可能会干扰宿主对HTLV-1抗原的识别。